Le Lézard
Classified in: Health
Subjects: NPT, BLK, CSR, DEI, ESG

Johnson & Johnson Vision Announces New Collaboration to Eliminate Inequities and Increase Representation of People of Color in the Eye Care Industry


JACKSONVILLE, Fla., Sept. 16, 2021 /PRNewswire/ -- Johnson & Johnson Vision*, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies**, today announced a collaboration with Black EyeCare Perspective, a not-for-profit organization dedicated to redefining the color of the eyecare industry 1% at a time. As part of the collaboration, Johnson & Johnson Vision signed the 13% Promise, an initiative to increase equity and representation in the eye care industry and in optometry schools by increasing the number of Black students to mirror the 13% of Black people in the U.S. population.

Click to Tweet: .@JNJVision announces new collaboration to increase representation of people of color in the eye care industry and colleges of optometry. Learn more: https://bit.ly/3k9iv5C

According to data from Black EyeCare Perspective, only 3.2% of students and 3.8% of faculty in optometry colleges are Black or African American, and this number drops to only 1.8% among practicing optometrists. Johnson & Johnson Vision is the first major eye health company to sign the 13% Promise, furthering a long-standing commitment to diversity, equity and inclusion through awareness, education, and empowerment in collaboration with associations, public and community organizations.

Johnson & Johnson Vision will contribute to the 13% Promise by continuing to:

"As one of the largest eye health companies, we have an opportunity to drive change and bring more diversity, equity and inclusion in our industry for the greater good of the many patients and doctors we serve," said Thomas Swinnen, President, North America, Johnson & Johnson Vision***. "Our partnership with Black EyeCare Perspective is one of the many ways we can further support the future of optometry and work together to create quality, equitable experiences along with healthier outcomes across communities."

To learn more about Johnson & Johnson Vision visit www.jjvision.com.  

About Johnson & Johnson Vision*
At Johnson & Johnson Vision, part of Johnson & Johnson Medical Devices Companies, we have a bold ambition: to change the trajectory of eye health around the world. Through our operating companies, we deliver innovation that enables eye care professionals to create better outcomes for patients throughout their lives, with products and technologies that address unmet needs including refractive error, cataracts and dry eye. In communities with greatest need, we work in collaboration to expand access to quality eye care, and we are committed to helping people see better, connect better and live better. Visit us at www.jjvision.com. Follow @JNJVision on Twitter and Johnson & Johnson Vision on LinkedIn.

About Johnson & Johnson Medical Devices Companies**
At Johnson & Johnson Medical Devices Companies, we are helping people live their best lives. Building on more than a century of expertise, we tackle pressing healthcare challenges, and take bold steps that lead to new standards of care while improving people's healthcare experiences. In surgery, orthopedics, vision and interventional solutions, we are helping to save lives and paving the way to a healthier future for everyone, everywhere.

© Johnson & Johnson Vision Care Inc., 2021. All rights reserved.

*Johnson & Johnson Vision represents the products and services of Johnson & Johnson Surgical Vision, Inc., Johnson & Johnson Vision Care, Inc., and the affiliates of both.
**The Johnson & Johnson Medical Devices Companies comprise the surgery, orthopedics, vision, and interventional solutions businesses within Johnson & Johnson's Medical Devices segment.
***Thomas Swinnen is an employee of Johnson & Johnson Vision Care, Inc. with oversight as the North American President of the Vision Care organization.

(PRNewsfoto/Johnson & Johnson Vision)

SOURCE Johnson & Johnson Vision


These press releases may also interest you

at 11:43
- Cochlear Limited , the global leader in implantable hearing...

at 11:35
The Bone Health and Osteoporosis Foundation (BHOF) announced today its call for nominees for the newly created Robert F. Gagel, M.D. Community Leadership Award. The award's intent is to recognize healthcare professionals who are instrumental in...

at 11:33
Celebrating the 40th anniversary of The Glaucoma Foundation, writer, performer and producer David Letterman was front and center at TGF's April 18th Gala in New York City, where he received the Foundation's inaugural Chairman's Spotlight Award....

at 11:30
CancerIQ, a best-in-class cancer-focused precision health platform, today announced it is seeking health systems to participate in the newly launched, large-scale research effort that will document...

at 11:15
Expomed Eurasia, the most important medical exhibition between Europe and Asia, is ready to house more than a hundred companies, to discover new technological trends and the most innovative products which are going to change deeply the health market....

at 11:15
Nora Pharma, a Canadian pharmaceutical company, has received approval for its first Biosimilar product. Nora Pharma, a wholly owned division of Sunshine Biopharma, has received approval from Health Canada for the commercialization of NIOPEG® (a...



News published on and distributed by: